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The cellular electro physiologic consequences of both re•
gional and global experimental ischemia and reperfusion 
were studied in the isolated cat myocardium, using con•
ventional microelectrode techniques. Oxygenated Ty•
rode's solution was perfused through the left anterior 
descending and circumflex coronary arteries, while the 
preparation was superfused with Tyrode's solution gassed 
with 95% nitrogen and 5% carbon dioxide. Electro•
physiologic characteristics of endocardial muscle cells 
were normal during coronary perfusion. When perfu•
sion was discontinued for 30 minutes, resting membrane 
potential was decreased by 21.6 ± 4.1 %, action poten•
tial amplitude was decreased by 29.1 ± 8.6% and action 
potential duration was decreased by 54.1 ± 12.5% (p 
< 0.001). Ectopic activity occurred after 5 to 10 minutes 
of ischemia and was more frequent in regional than in 
global ischemia (p < 0.05). Rapid ventricular activity 
was observed in only 5 (17 %) of 29 preparations during 
ischemia, whereas it occurred in 24 (83%) of 29 prep•
arations during reperfusion. Rapid ventricular activity 
began 5 to 40 seconds (mean 19) after the start of re•
perfusion, stopped spontaneously after a mean of 113 ± 
211 seconds and occurred after both regional and global 
ischemia. The cellular electrophysiologic changes in-
Potentially lethal arrhythmias in the presence of coronary 
artery disease have been attributed to the electrophysiologic 
consequences of both acute ischemia and reperfusion of 
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duced by ischemia returned to baseline values within the 
next 5 minutes. Repeated ischemia and reperfusion runs 
reproduced the same electrophysiologic changes and rapid 
ventricular activity. 
Coronary perfusion with procainamide (20 mglIiter) 
aggravated the ischemic depressions of action potential 
amplitude and action potential duration and increased 
conduction delay during ischemia, but it did not prevent 
rapid ventricular activity induced by reperfusion. In 
contrast, verapamil (1 mglliter) perfusion did not affect 
the changes in action potential variables during ischemia 
but prevented reperfusion-induced rapid ventricular ac•
tivity. Perfusion with calcium ion (Ca2 +)-free Tyrode's 
solution just before ischemia and during reperfusion 
slowed or prevented reperfusion-induced rapid ventric•
ular activity, without affecting the action potential changes 
during ischemia. 
It is concluded that, in these isolated perfused ventric•
ular muscle preparations, different mechanisms may be 
operative in ischemic and reperfusion arrhythmias and 
Ca2 + may play an important role in the development of 
arrhythmias during the reperfusion phase of isch•
emia/reperfusion sequences. 
(J Am Coli CardioI1986;7:833-42) 
transiently ischemic myocardium (1--4). Experimental models 
of coronary artery occlusion and reperfusion have been stud•
ied (5-8) in an attempt to understand the mechanisms of 
such ventricular arrhythmias. However, studies of cellular 
electrophysiologic changes during ischemia and reperfusion 
have been limited by the fact that intraceilular recordings 
are difficult to maintain in the vigorously beating in situ 
heart. Some investigators (9-11) have recorded changes in 
the characteristics of action potential during ischemia in vivo 
and in Langendorff-perfused hearts. However, the reports 
of ceitular electrophysiologic changes during ischemia and 
reperfusion in isolated cardiac tissues (12-15) have been 
limited to manipulation of superfusate to mimic the in situ 
environments of ischemia and reperfusion. 
The use of isolated cardiac tissue facilitates the recording 
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of transmembrane action potentials, and should provide more 
precise understanding of the electrophysiologic events oc•
curring at a cellular level during ischemia, reperfusion and 
pharmacologic interventions. In the present study, we de•
veloped a new model using the isolated cat ventricular myo•
cardium to monitor cellular electrophysiologic changes dur•
ing experimental ischemia (hereafter called ischemia) and 
reperfusion. We used this technique to study cellular changes 
during the sequences of ischemia and reperfusion, and their 
modification by ionic and pharmacologic interventions. We 
also could compare the consequences of regional ischemia 
followed by reperfusion with the consequences of global 
ischemia and reperfusion. 
Methods 
Experimental pteparation and perfusing solution. 
Domestic cats of either sex, weighing 1.9 to 3.5 kg, were 
anesthetized with sodium pentobarbital (30 mg/kg, intra•
peritoneally). The hearts were rapidly removed and im•
mersed in cool oxygenated Tyrode' s solution. After removal 
of both atria and the right ventricle, the left anterior de•
scending coronary artery was cannulated with a poly•
ethylene cannula (0.11 or 0.17 mm diameter, Intramedic, 
PE 10 or PE 50) through the left main coronary ostium in 
the aortic root. In preparations used for comparisons of 
global and regional ischemia, both the left anterior descend•
ing and circumflex arteries were cannulated. No more than 
5 minutes elapsed from the time the heart was excised to 
cannulation. The cannulas were secured in place with 6-0 
silk sutures and then perfused with Tyrode's solution equi•
librated with 95% oxygen and 5% carbon dioxide. The 
perfused area was distinctly delineated by its pale appear•
ance after injection of Tyrode' s solution. The tissue beyond 
the perfused area was excised, and the major branches of 
arteries transected by the dissection were ligated with 6-0 
silk sutures. After completion of the entire protocol, Evans 
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blue dye (Sigma) was injected to ensure that the preparations 
were well perfused. 
The cannulated preparations were placed with the en•
docardial surface up in a superfusion chamber of 100 ml 
volume, and then were superfused with Tyrode's solution 
gassed with 95% nitrogen and 5% carbon dioxide at a flow 
rate of 20 mllmin. The preparations were simultaneously 
perfused through the coronary cannulas with Tyrode's so•
lution gassed with 95% oxygen and 5% carbon dioxide at 
a perfusion rate of 0.8 to 1. 0 mll g wet weight per min using 
a peristaltic pump (Cole-Palmerlnc., model 7553-10) (Fig. 
1). The final wet weight of the perfused preparations in•
creased no more than 15% above the initial wet weight 
(mean ± SD 8 ± 5%). The temperatures of the perfusate 
and superfusate both were maintained at 37°C. The pH of 
the solutions was 7.35. The partial pressure of oxygen (Po2) 
of the perfusate was greater than 500 mm Hg, while the 
P02 of the supeifusate was 33 to 45 mm Hg. The compo•
sition of Tyrode's solution was (in millimolars): sodium 
chloride 129, potassium chloride 4, sodium bicarbonate 20, 
sodium dihydrogen phosphate 1.8, magnesium chloride 0.5, 
calcium chloride 2.7 and dextrose 5.5. 
Electrical stimulation and recording. Driving stimuli 
at a cycle length of 800 ms were delivered to the left bundle 
branch through bipolar Teflon-coated silver wire electrodes. 
Pulse duration was 3 ms and current strength was twice late 
diastolic threshold. Transmembrane action potentials were 
recorded by using standard techniques previously reported 
in detail (16). Glass microelectrodes, filled with 3 M po•
tassium chloride (direct current resistance 10 to 30 Mil), 
were connected through silver-silver chloride junctions to a 
high input impedance electrometer with input capacity neu•
tralization (WPI, model KS-700). Transmembrane action 
potentials were recorded from the endocardial muscle cells. 
Multiple impalements were required to provide continuous 
electrophysiologic data during ischemia and reperfusion. 
Bipolar electrograms were recorded using fine silver wire 
electrodes, Teflon-coated except at their tips (0.1 mm di-
Figure 1. Experimental arrangement. The isolated 
segment of the cat left ventricle was perfused with 
oxygenated Tyrode's solution through coronary artery 
cannulas. The preparation was simultaneously super•
fused with Tyrode's solution gassed with 95% nitrogell 
and 5% carbon dioxide to avoid oxygen supply from 
r,:::;2;===;==:=::o .... OUT the surface. Experimental ischemia was produced by 
discontinuing perfusion. LAD = left anterior descend•
ing coronary artery; LeX = left circumflex coronal) 
artery. 
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ameter). inserted into endocardium through a 26 gauge needle. 
The signals were amplified by a differential amplifier. The 
distance between the stimulating electrodes and the record•
ing electrodes was approximately 1.5 cm. The amplifier 
outputs were displayed on dual beam oscilloscopes (Tek•
tronix, 564 and 565) and recorded on Polaroid film and a 
polygraph (Grass, model 79). 
Action potential variables measured were resting mem•
brane potential, action potential amplitude and action po•
tential duration at 50 and 90% of repolarization (APDso and 
APD9o, respectively). Conduction time was estimated as the 
time interval between the upstroke of the stimulus artifact 
and the major deflection of the bipolar electrogram. 
Experimental arrhythmias produced during ischemia and 
reperjusion were recorded on film. They were defined as 
ectopic activity (single ectopic impulses or couplets) and 
rapid ventricular activity (rapid runs of ectopic impulses that 
lasted more than IO seconds). 
Experimental protocol. In the first series of experi•
ments. global or regional myocardial ischemia was produced 
by discontinuing coronary perfusion after a 45 to 60 minute 
equilibration period. Transmembrane action potentials and 
bipolar electrograms were continuously displayed and re-
Figure 2. Reproducibility of transmembrane action potential changes 
and rapid ventricular activity (equivalent to ventricular tachycardia 
or fibrillation) during experimental ischemia and reperfusion. A. 
Transmembrane action potential changes during the first 30 min•
utes of ischemia and rapid ventricular activity observed 10 seconds 
after reperfusion. Action potentials returned to normal within 5 
minutes of reperfusion. B, Transmembrane action potential changes 
during the second ischemic period and rapid ventricular activity 
observed 15 seconds after the second reperfusion. Horizontal lines 
represent zero potential. 
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Figure 3. Changes in transmembrane action potential character•
istics during experimental ischemia and reperfusion. Each filled 
circle represents the mean of 18 preparations. Vertical lines in•
dicate standard deviations. APA = action potential amplitude; 
APDsu and APDqo = action potential duration measured at 50 and 
90% of repolarization. respectively: RMP = resting membrane 
potential. 
corded on film every 10 minutes during the period of isch•
emia. The preparations were reperfused after 30 minutes of 
ischemia, using the same flow rate that had been used during 
the equilibration period before ischemia. During ischemia 
and reperfusion, ectopic activity was monitored by record•
ing transmembrane action potentials and bipolar electro•
grams on a polygraph. 
In the second series of experiments. discontinuation of 
coronary perfusion and subsequent reperfusion was repeated 
to validate the reproducibility of changes in action potential 
variables and the occurrence of rapid ventricular activity 
during ischemia and reperfusion. 
In the third series of experiments. we examined the ef•
fects of procainamide, verapamil and Ca2 + -free perfusate 
solution on the cellular electrophysiologic changes and on 
the occurrence of rapid ventricular activity during ischemia 
and reperfusion. After 30 minutes of reperfusion, following 
the first 30 minutes of ischemia, one of the following per•
fusate changes was made: I) procainamide hydrochloride 
(Sigma), 20 mg/liter, was added to the perfusate; 2) 1-
verapamil hydrochloride (Knoll AG Fhemishe Fabriken, 
Ludwigshafen am Rein, West Germany), I mg/liter was 
added to the perfusate; or 3) calcium-free Tyrode's solution 
was used instead of perfusate with normal Ca2 + content. 
After a period of perfusion with new perfusate (see Results 
section for duration of each intervention), 30 minutes of 
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ischemia and subsequent reperfusion were carried out with 
the procainamide, verapamil or Ca2+ -free intervention. 
Statistical analysis. All data are expressed as the mean 
± SD and were evaluated for statistical significance by 
analysis of variance with repeated measures or Student's 
unpaired t test, whichever was appropriate. Differences with 
probability (p) values less than 0.05 were considered 
significant. 
Results 
Changes in transmembrane action potentials during 
ischemia and reperfusion. Transmembrane action poten•
tials were recorded from the endocardial ventricular muscle 
cells after a 45 to 60 minute equilibration period (control). 
Discontinuing coronary perfusion produced a progressive 
loss of resting membrane potential, action potential ampli•
tude and action potential duration (Fig. 2A). After 30 min•
utes of ischemia, resting membrane potential was decreased 
by 21.1 ± 4.1 % (mean ± SD), action potential amplitude 
was decreased by 29.1 ± 8.6%, 50% repolarizatiaon time 
(APDso) was decreased by 64.5 ± 14.8% and 90% repo•
larization time (APD90) was decreased by 54.1 ± 12.5% 
(Fig. 3). The differences between control and ischemic pe•
riods were significant for all measurements (p < 0.001, n 
= 18). Spontaneous firing rate was transiently enhanced 
over the stimulation rate approximately 10 minutes after 
stopping perfusion in II (38%) of 29 preparations. How•
ever, by the end of 30 minutes of ischemia, the automaticity 
was decreased again and the preparations responded to the 
stimulation. During the 30 minute period of ischemia, ec•
topic activity developed at 5 to 10 minutes in 21 (72%) of 
29 preparations, and its frequency peaked in the 20 to 30 
minute time period. However, rapid ventricular activity was 
recorded in only 5 (17%) of the 29 preparations. Electrical 
aIternans in action potential duration often accompanied 
ectopic activity, but aIternans was also recorded in the ab•
sence of ectopic activity. In four preparations in which per•
fusion was stopped for 60 minutes, no further changes in 
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action potentials were observed during the 30 to 60 minute 
period of ischemia, and ectopic activity was rarely recorded. 
When perfusion was reestablished after 30 minutes of 
ischemia, ectopic activity was recorded in all of the 29 
preparations. Rapid ventricular activity began 19 ± 8 sec•
onds (range 5 to 40) after reestablishment of flow in 24 
(83%) of the 29 preparations. Rapid ventricular activity 
during reperfusion lasted for 113 ± 211 seconds (range 10 
to 1,020) and stopped spontaneously. The cellular electro•
physiologic changes that had been induced by ischemia re•
turned to baseline values within the next 5 minutes (Fig. 
2A and 3). 
Reproducibility of changes in transmembrane action 
potentials and rapid ventricular activity during ischemia 
and reperfusion (Table 1). Repeated sequences of isch•
emia and reperfusion were examined in six preparations to 
test the reproducibility of the experimental system. Figure 
2B illustrates a typical experiment. When a second period 
of ischemia was produced by discontinuing perfusion after 
the 30 minutes of reperfusion following the first 30 minutes 
of ischemia, the reductions of resting membrane potential, 
action potential amplitude and action potential duration dur•
ing the second ischemic period were nearly identical to those 
recorded during the first period, although the degree of the 
reduction of action potential amplitude tended to be small 
during the 10 to 20 minute interval of the second ischemic 
period. The changes in action potentials induced by repeated 
periods of ischemia are summarized in Table I. Figure 2 
also shows that rapid ventricular activity which developed 
10 seconds into the first reperfusion period was also repro•
duced 15 seconds into the second reperfusion period. In 
these reproducibility experiments, rapid ventricular activity 
had been recorded from five of six preparations during the 
first reperfusion, and also occurred during the second period 
of reperfusion in four of these five preparations. In the sixth 
preparation, rapid ventricular activity was not recorded dur•
ing either the first or second reperfusion. 
Rapid ventricular activity during reperfusion after 
different durations of ischemia. The occurrence of rapid 
Table 1. Reproducibility of Changes in Action Potential Characteristics During Experimental Ischemia and Reperfusion (n = 6) 
RMP (-mV) APA (mV) APD50 (ms) APD90 (ms) 
First Ischemic penod 
Before ischemia 80.7 :±: 2.1 1110 :±: 4.1 159.5 :±: 16.9 207.8 :±: 14.9 
Ischemia (30 min) 64.0 :±: 3.2 82.2 :±: 7.4 50.3 :±: 9.6 92.3 :±: 11.5 
ReperfuslOn (5 mm) 81.0 :±: 2.1 111.3 :±: 5.0 156.7 :±: 14.2 203.8 :±: 20.0 
Second ischemiC period 
Before ischemia 80.3 :±: 2.0 110.8 :±: 4.9 162.7 :±: 15 I 205.8 :±: 18.2 
Ischemia (30 min) 63 6 :±: 3.8 80.7 :±: 84 41.3 :±: 10.5 84.0 :±: 27.5 
ReperfuslOn (5 mm) 79.5 :±: 1.5 108.7 :±: 3.8 142.3 :±: 21.3 186.8 ± 20.6 
Data are expressed as the mean ::t: SD. The second period of ischemia was produced after 30 minutes of reperfusion following the first 30 minutes 
of ischemia. APA = actIOn potenlial amplitUde; APD50 and APD90 = action potential duration measured at 50 and 90% of repolarization, respectively; 
RMP = resting membrane potential. None of comparisons between the first and second Ischemic periods show statistical significance. 
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Table 2. Effects of Procainamide on Changes m Action Potential Characteristics During Experimental Ischemia (n == 5) 
RMP (mV) APA (mV) APOso (fiS) AP09Q (fiS) 
Before ischemia 
Control 81.4 :!: 1.5 1126 ± 52 143.2 ± 16.4 180.6 ± 12.4 
191.6 ± 11.8 Procamamide 80.4 ± OS 109.8 :!: 4.0 145.0 ± 14.6 
Ischemia (30 min) 
Control 62.4 ± 0.9 82.0 ± 33 61.6 ± 18.5 94.0 ± 14.3 
55.0 ± 6.0t Procainamlde 61.6 ± 0.9 61.0 ± 11.0* 28.0 ± 10.5* 
*p < 0.01 versus control values; tp < 0.001 versus control values. Data are expressed a, mean ± SO. Control = values obtained before and during 
the first period of ischemia; procainamlde = values obtained before and during the second penod of ischemia in the presence of procainamide. Abbreviations 
as in Table I. 
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Figure 4. Effects of procainamide (20 mg/liter) on transmembrane 
action potential changes during experimental ischemia and rapid 
ventricular activity during reperfusion. A, Transmembrane action 
potential changes during the first ischemic period and rapid ven•
tricular activity observed 30 seconds after reperfusion. B, Trans•
membrane action potential changes during the second ischemic 
period and rapid ventricular activity observed 30 seconds after the 
second reperfusion, in the presence of procainamide. Procainamide 
aggravated the ischemic depression of action potential amplitude 
and duration, but did not prevent reperfusion-induced rapid ven•
tricular activity. 
ventricular activity during reperfusion was studied as a func•
tion of the duration of preceding period of ischemia. The 
preparations were reperfused after 10, 20 or 60 minutes of 
ischemia. Different preparations were used for the experi-
ments with different durations of ischemia. None of four 
preparations developed rapid ventricular activity during re•
perfusion after 10 minutes of ischemia. Rapid ventricular 
activity was recorded during reperfusion in one (25%) of 
four preparations after 20 minutes of ischemia. As previ•
ously mentioned, 24 (83%) of 29 preparations developed 
rapid ventricular activity after 30 minutes of ischemia. Longer 
duration of ischemia (60 minutes) resulted in rapid ventric•
ular activity during reperfusion in four 000%) of four 
preparations. 
Effects of procainamide (Table 2). The effect of pro•
cainamide on changes in action potential variables and the 
occurrence of rapid ventricular activity during ischemia and 
reperfusion were studied in five preparations. After 30 min•
utes of reperfusion following 30 minutes of a control isch•
emia study, the preparations were perfused with Tyrode' s 
solution containing procainamide (20 mg/liter) for 30 min•
utes. This was followed by a second 30 minute period of 
ischemia with subsequent reperfusion with procainamide 
containing Tyrode's solution. Perfusion with procainamide 
for 30 minutes before the second ischemic period tended to 
prolong action potential duration, but did not affect the other 
cellular electrophysiologic variables. During ischemia, ac•
tion potential amplitude and action potential duration were 
reduced to a greater degree in the presence of procainamide 
than during the control period of ischemia, but no effect of 
procainamide on resting membrane potential was recorded 
(Fig. 4). Conduction delay (an increase in conduction time 
between the stimulating and recording electrodes) was en•
hanced by procainamide (see Table 5). Among five prep•
arations that developed rapid ventricular activity during the 
Table 3. Effects of Verapamil on Changes in Action Potential Characteristics During Experimental Ischemia (n = 5) 
RMP(-mV) APA (mV) APOso (ms) AP090 (ms) 
Before ischemia 
Control 818 ;±: 1.9 110.6 :!: 4.2 151.2 ± 11.1 189.4 ± 9.1 
Verapamil 81.0 ;±: 1.0 109.2 ± 3.1 124.0 ± S.9t 170.2 ± 7.8* 
Ischemia (30 min) 
Control 62.7 ;±: 2.3 79.4 :!: 8.0 79.6 ± 19.2 110.2 ± 19.9 
Verapamil 62.6 ± 2.0 81.2 ± 10.5 54.0 :!: 23.2 85.2 ± 26.6 
*p < 0.05 versus control values; tp < 0.01 versus control values. Data are expressed as the mean:!: SO. Abbreviations as m Table I. 
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Figure 5. Effects of verapamil (I mg/liter) on transmembrane 
action potential changes during experimental ischemia and rapid 
ventricular activity during reperfusion. A, Transmembrane action 
potential changes during the first ischemic period and rapid ven•
tricular activity observed 20 seconds after reperfusion. B, Trans•
membrane action potential changes during the second ischemia 
reperfusion period, in the presence of verapamil. Verapamil did 
not affect the changes in action potential characteristics during 
ischemia but prevented reperfusion-induced rapid ventricular activity. 
first (control) reperfusion, procainamide failed to prevent 
the arrhythmia in four and prevented it in only one. 
Effects of calcium (Ca2 + )jree solution (Table 4). To test 
whether the preventive effects of verapamil on rapid ven•
tial characteristics and the occurrence of rapid ventricular 
activity during experimental ischemia and reperfusion were 
studied in five preparations. During reperfusion after the 
first 30 minutes of ischemia, the preparations were perfused 
with normal Tyrode's solution for 30 minutes, then with 
Tyrode's solution containing verapamil (l mg/liter) for the 
next 15 minutes of the reperfusion period. This was followed 
by the second 30 minutes of ischemia with subsequent re•
perfusion with verapamil-containing Tyrode's solution. Per-
lAce Vol 7. No ..( 
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fusion with verapamil for 15 minutes before the second 
ischemic period shortened action potential duration, but did 
not affect the other variables. During ischemia, action po•
tential duration tended to be shortened to a greater degree 
in the presence of verapamil, but the changes in resting 
membrane potential and action potential amplitude were 
similar with and without verapamil (Fig. 5). Conduction 
time was not affected by verapamil either before or during 
ischemia (see Table 5). Rapid ventricular activity, which 
occurred during the control reperfusion period in all five 
preparations, did not occur in any of the preparations during 
the second reperfusion period in the presence of verapamil 
(Fig. 5B). Verapamil at a concentration of 0.1 mg/liter did 
not affect action potential variables and conduction time 
either before or during ischemia and prevented reperfusion•
induced rapid ventricular activity in only two of four prep•
arations studied. 
Effects of calcium (Ca2 + i-free solution (Table 4). To test 
whether the preventive effects of verapamil on rapid ven•
tricular activity induced by reperfusion are related to the 
blocking action of verapamil on the Ca2+ inward current, 
we examined the effects of coronary perfusion with Ca2 + -
free solution on changes in action potential variables and 
the occurrence of rapid ventricular activity during ischemia 
and reperfusion in seven preparations. After the first 30 
minutes of ischemia and 30 minutes of reperfusion, the 
preparations were perfused with Ca2+ -free Tyrode's solu•
tion for 3 minutes. Then the 30 minutes of ischemia and 
subsequent reperfusion with Ca2+ -free Tyrode's solution 
were repeated. Perfusion with Ca2+ -free solution for 3 min•
utes did not affect cellular electrophysiologic variables and 
conduction time either before or during ischemia (Fig. 6, 
Tables 4 and 5). However, rapid ventricular activity, which 
had been recorded during the first control reperfusion period 
in all seven preparations, was not observed in four of the 
seven preparations during the second reperfusion with Ca2 + -
free solution (Fig. 6B). In two of the three preparations in 
which rapid ventricular activity was not inhibited, its rate 
was reduced from 624 to 320 impulses/min and from 480 
to 288 impulses/min, respectively. Rapid ventricular activity 
during reperfusion was not influenced at all in only one of 
Table 4. Effects of Ca2 + -free Tyrode's Solution on Changes in Action Potential Characteristics During Experimental 
Ischemia (n = 7) 
RMP (-mV) APA (mV) APD50 (ms) ADP9tl (ms) 
Before ischemia 
Control 80.0 ± 2.0 110.7 ± 49 156.9 ± 16.7 205.4 ± 17.3 
Ca2 + -free solution 78.9 ± 1.1 107.0 ± 3.2 156.1 ± 15.9 197.7 ± 16.8 
Ischemia (30 min) 
Control 63.4 ± 4.0 74.6 ± 12.8 40.6 ± 21.9 79.1 ± 27.7 
Ca2 + -free solutIOn 60.4 ± 5.5 78.8 ± 16.7 46.8 ± 23.8 98.6 ± 36.4 
Data are expressed as the mean ± SD. None of the comparisons between control and Ca2 + -free solution show statistical SIgnificance. Abbreviations 
as in Table I. 
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Figure 6. Effects of calcium-free Tyrode's solution on transmem•
brane action potential changes during experimental ischemia and 
rapid ventricular activity during reperfusion_ A, Transmembrane 
action potential during the first ischemic period and rapid ventric•
ular activity observed 30 seconds after reperfusion. B, Transmem•
brane action potential changes during the second, ischemic period 
and ectopic activity observed 30 seconds after the second reper•
fusion, in the presence of calcium-free solution. Calcium-free so•
lution did not affect the changes in action potential characteristics 
during ischemia but prevented reperfusion-induced rapid venttic•
ular activity. 
the seven preparations_ In the six preparations in which 
Ca2 + -free solution suppressed rapid ventricular activity or 
reduced its rate during reperfusion, a second control reper•
fusion experiment, using normal Ca2+ -containing Tyrode's 
solution, resulted in recurrence of rapid ventricular activity. 
Regional versus global ischemia. The preceding results 
were collected in the preparations in which the left anterior 
descending artery only was cannulated and global ischemia 
was produced. In another 12 preparations, both the left 
anterior descending and circumflex arteries were cannulated 
and perfused separately. Regional ischemia was produced 
by discontinuing perfusion of the left anterior descending 
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artery bed and maintaining perfusion of the circumflex artery 
bed. Figure 7 A shows that when perfusion of the left anterior 
descending artery bed was discontinued, action potentials 
recorded from the affected myocardium showed changes 
related to ischemia, while those recorded from the circutn•
flex artery region, which was continuously perfused, were 
normal. At 30 seconds after reperfusion, rapid ventricular 
activity occurred and continued for 3 minutes, after which 
it stopped spontaneously. Action potentials in the region 
served by the left anterior descending artery returned to 
control at 8 minutes. In the same preparation, when per•
fusion of both vascular beds was stopped simultaneously 
after 30 minutes of reperfusion (Fig. 7B), action potentials 
in both regions deteriorated similarly, and rapid ventricular 
activity occurred 20 seconds after the second reperfusion. 
In eight preparations, ectopic activity observed during 
the 20 to 30 minute periods of ischemia were quantitated 
and compared for regional ischemia and global ischemia 
(Table 6). Ectopic activity was more frequently recorded in 
regional than in global ischemia (p < 0.05). However, rapid 
ventricular activity was induced by reperfusion in both re•
gional ischemia (9 of 12 preparations) and global ischemia 
(l0 of 12 preparations). 
Discussion 
Consideration of the model. Isolated segments of the 
cat left ventricle were perfused with oxygenated Tyrode's 
solution through cannulas in the coronary arteries. This new 
model permitted the study of either regional or global isch•
emia. To avoid oxygen supply from the surface, the prep•
arations were superfused simultaneously with Tyrode's so•
lution gassed with nitrogen. Despite superfusion with solution 
gassed with nitrogen, which shortens action potential du•
ration (7), the endocardial surface cells showed normal 
action potentials after an equilibration period, indicating that 
adequate oxygen was supplied to the cells through the coro-
Table 5. Effects of Procainamide, Verapamil and Calcium (Ca2 +)-Free Tyrode's Solution on 
Conduction Time During Ischemia 
Conduction Time (ms) 
Before Ischemia Ischemia 30 mm 
Procainamlde (n = 5) 
Control 16.70 ± 1.70 24.04 ± 4.60 
Procainamlde 17 .62 ± 1.94 35.00 ± 6.10* 
Verapamil (n = 5) 
Control 14.06 ± 5.01 20.64 ± 517 
Verapamil 14.66 ± 4.86 19.22 ± 3.60 
Ca2 + - free solution (n = 4) 
Control 18.85 ± 2.50 24.35 ± 5.39 
Calcium-free solution 18.05 ± 1.92 24.63 ± 6.90 
*p < 0.05 versus control values Data are expressed as the mean ± SD. Control = values obtained before 
and during first ischemia; procainamide, verapamil or calcium-free solution = values obtained before and 
during the second ischemia in the presence of procainamide, verapamil or calcium-free solution. 
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Figure 7. Comparison of the effects of regional and global ex•
perimental ischemia. A, During regional ischemia (stopping per•
fusion of the left anterior descending artery bed only), the trans•
membrane action potential recorded from the left anterior descending 
(LAD) artery region deteriorated, whereas that recorded from the 
left circumflex (LCX) artery region, which was continuously per•
fused, remained normal. Reperfusion of the left anterior descend•
ing artery bed induced rapid ventricular activity at 30 seconds. B, 
Using the same preparation, global ischemia was produced by 
stopping perfusion of both the left anterior descending and cir•
cumflex artery beds after 30 minutes of reperfusion. Transmem•
brane action potentials in both regions deteriorated similarly. Re•
perfusion of both beds again induced rapid ventricular activity at 
20 seconds. 
nary perfusate. When coronary perfusion was stopped, de•
terioration of action potential characteristics was recorded 
from the endocardial cells. This finding is similar to the 
previous observation in ischemic myocardial cells after 
coronary artery ligation in porcine hearts (11, 18). Reper•
fusion after 30 minutes of ischemia resulted in a rapid re•
covery of transmembrane action potentials in affected myo•
cardium, and repeated ischemia produced the same changes 
in action potentials as those observed during the first run of 
ischemia. Rapid ventricular activity was reproducibly re•
corded in 24 (83%) of 29 preparations during the first 5 to 
40 seconds of the reperfusion phase of serial isch•
emialreperfusion sequences. 
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Recently, the cellular electrophysiologic effects of isch•
emia have been studied in an attempt to understand the 
mechanisms of ventricular arrhythmias during ischemia and 
reperfusion. In some studies, isolated tissues obtained from 
ischemic or infarcted hearts have been used to characterize 
ischemic changes (19,20). The drawback of this approach 
is that the tissues are no longer ischemic at the time of in 
vitro study. In addition, superfusion with the solution con•
taining adequate oxygen and substrate results in the recovery 
of the ischemic changes (9). In other studies, the super•
fusate was altered to mimic the in vivo environments of 
ischemia, such as low Po2 , high potassium concentration 
and low pH 02-15). Because there are limits to the inter•
pretation of changes occurring in ischemic myocardium in 
various stages and intensities of ischemia produced by these 
methods, the model of ischemia used in the present study 
was designed to more closely mimic ischemic events oc•
curring in in vivo experiments. Furthermore, the sponta•
neous sustained arrhythmias observed in the present study 
have not been induced in the tissue bath, especially during 
washout (reperfusion). Our model provides a reproducible 
method for the study of cellular electrophysiologic changes 
and arrhythmias during acute ischemia and reperfusion. 
The onset of rapid ventricular activity on reperfusion is 
identical to reperfusion arrhythmias that occur in in vivo 
experiments (6-8). However, the rapid ventricular activity 
observed in our study terminated spontaneously, unlike the 
ventricular tachycardia or fibrillation observed in intact an•
imals (6-8). The myocardial mass used in the present study 
might be below the critical level for maintaining rapid ven•
tricular activity (21). The discrepancy might also be ascribed 
to our experimental condition that, during reperfusion, the 
preparations were constantly perfused, even when rapid ven•
tricular activity was developed. The development of ven•
tricular fibrillation causes deterioration of coronary circu•
lation in in vivo experiments. 
Effects of procainamide. Our data demonstrate that 
procainamide aggravated the reductions of action potential 
amplitude and action potential duration without affecting 
the change in resting membrane potential during experi•
mental ischemia. The ischemia-related prolongation of con•
duction time was further prolonged in the presence of pro-
Table 6. Number of Ectopic Activity Impulses During Experimental Ischemia and the Incidence 
of Rapid Ventricular Activity During Reperfusion 
Regional ischemia 
Global ischemia 
Number of Ectopic Activity 
Impulses During Ischemia 
(n = 8) 
57 ± 47 impulsesllO min" * 
10 ± 18 impulses/IO min / 
Incidence of Rapid Ventricular 
Activity During Reperfusion 
(n = 12) 
9 of 12 (75%) 
10 of 12 (83%) 
*Ischemia-induced ectopic activity was more frequently recorded in regional Ischemia than in global Ischemia 
(p < 0.05). Data on the number of ectopic activity impulses are expressed as mean values ± SO. The number 
of ectopic activity impulses was counted during the last 20 to 30 minute period of ischemia. 
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cainamide. These findings are consistent with the depressant 
effect of procainamide on damaged or depolarized tissues 
(22,23). Sodium channel blocking antiarrhythmic drugs are 
more depressant in depolarized tIssues, and selective depres•
sion of depolarized tissues is now considered a major mech•
anism of their action (24). However, procainamide was 
found to be ineffective for reperfusion-induced rapid ven•
tricular activity in this study. 
Effects of verapamil. Verapamil was shown to prevent 
the rapid ventricular activity observed during reperfusion, 
without affecting the changes in action potential character•
istics during experimental ischemia. This effect of verapamil 
on reperfusion-induced arrhythmias was similar to that ob•
served in previous in vivo studies (25,26). Possible mech•
anisms by which verapamil exerts its effect on reperfusion 
arrhythmias should include direct electrophysiologic effects, 
reduced Ca2 + overload as a result of inhibition of the slow 
inward Ca2 + current and reduction of metabolic demand. 
The direct electrophysiologic actions of verapamil are 
particularly evident in depolarized or ischemic myocardium 
(27,28). If slow responses are generated in reperfused myo•
cardium, verapamil might abolish a pathway necessary for 
reentry as a result of suppression of slow responses. 
Another possibility might be that verapamil decreased 
Ca2 + overload in myocardial cells during ischemia and 
reperjusion and maintained the cell function (29). resulting 
in the suppression of rapid ventricular activity. This as•
sumption might be supported by the finding that when Cae + -
free solution was perfused just before ischemia and during 
reperfusion, the incidence of rapid ventricular activity on 
reperfusion was reduced. If this is the case, it may explain 
why procainamide, which has little action on the slow in•
ward Ca2 + current, was ineffective for r~perfusion-induced 
rapid ventricular activity. However, compared with the ef•
fects of verapamil, Cal + -free solution did not show a dra•
matic suppressing effect on rapid ventricular activity in•
duced by reperfusion. Some other verapamil-mediated 
mechanisms might be involved, such as reduction in ac•
cumulation of washout products of ischemia, especially po•
tassium (30,31). It is also possible that there was still a 
significant amount of calcium in the extracellular space de•
spite perfusion with Ca2 + -free solution. 
Finally, it should also be considered that reduction of 
myocardial metabolic requirements by verapamil and Ca:! + 
free solution during ischemia might have reduced myo•
cardial damage and suppressed rapid ventricular activity on 
reperfusion. However, we did not observe salutary effects 
of these interventions on cellular electrophysiologic dete•
rioration induced by ischemia. 
Role of calcium in reperfusion arrhythmias. It is in•
teresting that during ischemia, ectopic activity was more 
frequently observed in regional ischemia than III global isch•
emia, but rapid ventricular activity was induced by reper•
fusion in both regional and global ischemia. This finding 
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suggests that different mechanisms may be operative in isch•
emia-induced and reperfusion-induced arrhythmias. Reentry 
is generally regarded as the plausible explanation for the 
early ischemic arrhythmias (5,32). However, the mecha•
nism or mechanisms underlying the arrhythmias during re•
perfusion still remain unsettled. Although it is impossible 
to state the exact mechanism of reperfusion arrhythmias 
from this study, our data suggest that Ca2 + may play an 
important role in the development of reperfusion arrhythmias. 
We gratefully acknowledge 1acquelme Peres for preparations of the 
manuscnpt. 
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